Shanghai Pharmaceutical: Application for marketing of perindopril tert-butylamine API approved

Breakings ·  May 20 16:06
Shanghai Pharmaceutical announced that the marketing application for perindopril tert-butylamine as an API was approved.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment